BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8930189)

  • 21. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J; Dougherty JJ; Nichols RA
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
    Nagashima M; Yamada K; Kimura H; Matsumoto S; Furukawa T
    Pharmacol Biochem Behav; 1992 Dec; 43(4):993-7. PubMed ID: 1361996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic mechanisms controlling urethral function in rats.
    Ogawa T; Seki S; Masuda H; Igawa Y; Nishizawa O; Kuno S; Chancellor MB; de Groat WC; Yoshimura N
    Neurourol Urodyn; 2006; 25(5):480-9. PubMed ID: 16721842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart.
    Dlewati A; Watkins HO; Lokhandwala MF
    Eur J Pharmacol; 1989 May; 164(2):197-203. PubMed ID: 2569408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of alpha2-adrenergic inhibition of sympathetic ganglionic transmission.
    McCallum JB; Boban N; Hogan Q; Schmeling WT; Kampine JP; Bosnjak ZJ
    Anesth Analg; 1998 Sep; 87(3):503-10. PubMed ID: 9728818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK
    Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF; Sabouni MH
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcholine stimulation of the sympathetic ganglia: effects of taurine and nicotinic and muscarinic ganglion block.
    Hilton JG
    J Pharmacol Exp Ther; 1977 Nov; 203(2):426-34. PubMed ID: 71348
    [No Abstract]   [Full Text] [Related]  

  • 35. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible inhibitory role of endogenous gamma-aminobutyric acid in the nonnicotinic functions of the dog cardiac sympathetic ganglia.
    Kushiku K; Furukawa T
    J Pharmacol Exp Ther; 1985 Jun; 233(3):810-5. PubMed ID: 2861281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors.
    Frye CA; Walf AA; Sumida K
    Pharmacol Biochem Behav; 2004 Jul; 78(3):405-18. PubMed ID: 15251249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
    Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
    Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.